PAVmed (PAVM)

• Market cap: $6.44M
• 1 day: -3.82%
• 5 days: -24.42%
• 1 month: -43.50%
• 3 months: -63.85%
• 6 months: -31.82%
• Year to date: -85.67%
• 1 year: -84.60%
• 5 years: -96.11%
• 10 years: -99.70%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.

Employees: 107

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

47% more capital invested

Capital invested by funds: $936K [Q2] → $1.38M (+$443K) [Q3]

0.91% less ownership

Funds ownership: 11.67% [Q2] → 10.77% (-0.91%) [Q3]

15% less funds holding

Funds holding: 26 [Q2] → 22 (-4) [Q3]

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $19 3,165% upside
• Avg. target: $19 3,165% upside
• High target: $19 3,165% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Ascendiant Capital Edward Woo 38% 1-year accuracy 28 / 73 met price target

3,165% upside $19

Buy Maintained

9 Dec 2024